Press release
Autoinjector Landscape Changing as Suppliers Re-evaluate Market Opportunities
(Amherst, NH) – Autoinjectors, which first appeared as an accessory device to aid in the administration of injectable drugs supplied in prefilled syringes, have grown to become a significant medical device market segment. As the number of drugs available in prefilled syringes as a percentage of all injectable drugs has grown, autoinjectors have experienced healthy and consistent demand, resulting in expanding competition and proliferating device product lines. Now, in response to an evolving injectable drug market, autoinjector suppliers have been re-evaluating and adjusting their product strategies to better reflect changing market conditions.Suppliers of autoinjectors face several challenges as the market evolves and matures. Continued interest in plastic prefilled syringes will require non-brand specific injector manufacturers to validate that their devices function consistently and safely over the range of these emerging PFS devices – devices with rigidity, barrel lubricity and flexural properties that differ from type 1 glass syringes. They will have to compete – in some cases head-on – with prefilled syringe suppliers, who are increasingly incorporating autoinjector-like ease-of-use features into their PFS designs to differentiate their product lines and in some cases to meet their pharmaceutical customer requirements for product-specific syringe designs.
In the past 24 months, the competitive landscape has evolved as companies in the autoinjector market segment advance or recede from their former positions within the market. SHL Medical continues to be aggressive in terms of facilities and infrastructure investment at its manufacturing hub (Taiwan), and remains the autoinjectors segment leader in terms of the number of branded autoinjector products. Ypsomed’s autoinjector offerings have shifted as the company consolidates its injection device business to reflect a decrease in OEM customer business and as it continues to build its diabetes franchise which is being driven in large part by its distribution agreement with Insulet (USA) for the OmniPod wearable insulin pump.
Owen Mumford has retired several of its autoinjector products from the market, while Consort’s Bespak division has announced a new platform of power assisted injectors. Becton Dickinson continues to be deliberate in its approach to this segment. The company introduced a new prefillable syringe designed to be paired with its Physioject autoinjector for the delivery of biological drugs. Haselmeier is promoting a line of five injection devices that accept 3 mL cartridges, however the company no longer offers an autoinjector designed for use with a standard prefilled syringe.
A new and comprehensive report analyzing autoinjectors and autoinjection device products and markets prepared by Greystone Research Associates is now available. The report – Autoinjectors to 2020 - provides analysis and assessments of commercial autoinjectors, analysis of market and therapeutic injectable drug factors that are influencing autoinjector growth, profiles of market sector participants, and detailed assessments of strategic and economic factors.
More information is available at http://www.greystoneassociates.org
Source: Greystone Research Associates
About Greystone
Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
Contact:
Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-218-7020
www.greystoneassociates.org
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autoinjector Landscape Changing as Suppliers Re-evaluate Market Opportunities here
News-ID: 289862 • Views: …
More Releases from Greystone Research Associates
Seeking to Capitalize on New Device Technology Drug Companies are Reformulating …
(Amherst, NH) – As the pace of competition increases within the pharmaceutical and biotech industries, the concept of life cycle management is becoming a key component of drug product management. Much of the recent emphasis in this area has centered on efforts to extend patent rights protection. While reformulation has been and is an important approach, efforts to prolong IP benefits have only recently involved IV-to-SC drug re-engineering. This migration…
Antibacterial Treatments that don’t Rely on Antibiotics Winding their way thro …
(Amherst, NH) – As bacteria grow resistant to conventional antibiotics, alternatives are being investigated, including antibodies, probiotics, bacteriophages, and antimicrobial peptides. The quest to replace the current generation of antibiotics is complicated by the methods that bacteria have acquired to evade attempts to destroy them – methods often referred to a virulence factors.
A microorganism can possess a wide array of virulence factors. They may only express these virulence factors when…
3D Printing Positioned to Address Issues that have Prevented Wide Adoption of Mi …
(Amherst, NH) – The promise of commercial microneedle drug delivery has been on the horizon for more than a decade. Like other compelling medical device innovations such as noninvasive glucose monitoring, the potential of the technology has yet to be realized due to the inability to solve the issues of reliable product performance from unit to unit and across a wide user population.
To fully address the unmet need these technologies…
Analysis of the Oncology Drug Pipeline Reveals Evolving Therapy Correlations and …
(Amherst, NH) – The almost two thousand active oncology clinical trials paint a picture of an evolving therapeutic sector that has established players moving quickly to realize the expanded benefits of recent treatment protocols. A dozen targeted treatments, using novel pathways and signaling, have achieved results that represent a new era in oncology and antineoplastic therapeutics. There approaches have attracted a growing number of drug developers anxious to profit from…
More Releases for Amherst
Future Growth : Crop Nutrient Management Market Sees Promising Growth in 2022 SM …
Worldwide Market Reports has added a new research study on Global "Crop Nutrient Management Market" 2022 by Size, Growth, Trends, and dynamics, Forecast to 2028 which is a result of an extensive examination of the market patterns. This report covers a comprehensive investigation of the information that influences the market regarding fabricates, business providers, market players, and clients. The report provides data about the aspects which drive the expansion of…
A New Generation of Glucose Sensors is Creating Options for Caregivers and their …
(Amherst, NH) – The convergence of small-scale electronics and sophisticated biocompatible product designs is giving hope for a better future to millions of diabetes patients worldwide. New glucose sensors that can measure glucose levels accurately and reliably have the capability to improve glycemic control and patient wellbeing. By utilizing new technologies for sensing glucose, this new class of sensors is creating new options for caregivers and their diabetes patients. Signal…
New Aircraft Designs Creating Opportunities for High Performance Aerospace Coati …
(Amherst, NH) – As aerospace manufacturers and their engineering teams push the design envelope to create aircraft with better fuel efficiency and lower maintenance requirements, they are relying increasingly on engineered materials for a growing list of structural and non-structural elements and components. This trend is changing the way aircraft are developed, produced and maintained. It’s also presenting opportunities for specialty materials suppliers with products that can improve production…
Evolution in Markets for Radiation Curable Coatings Creating Risks and Opportuni …
(Amherst, NH) – Recent advances in materials and equipment are creating new demand for radiation curable coatings in a number of industrial applications. This new demand is occurring as several technology advances are being brought into the marketplace. By removing some of the key limitations of radcure coatings, these advances are enabling radcure coatings to meet unique application requirements, opening up a number of new opportunities.
Technical advances that are having…
Adhesive Films and Tapes Evolving to Address Demands of Emerging Applications
(Nashua, NH) – Recent advances in adhe¬sives technology are creating new opportunities for adhesive films and tapes in a number of industrial applications. These adhesive products are finding new structural bonding and join¬ing applications in the automo¬tive, aerospace, and electronics markets. Films and tapes with enhanced performance are reaching the market as several important developments are occurring which will spur new demand. These findings are contained in a new market…
Adros Energy Expands Clean Energy Business with Energy Audit Services and opens …
Adros Energy; a leading green energy company in New England, announced today that they are opening a new headquarters in Amherst, NH after a successful 1st year of operation in the renewable energy market. The company was founded in January of 2009 and has found success during the incubation period of the company. The infrastructure building of the company in 2009 includes:
• Revenue generation from its solar PV,…
